Open Science project funded for $1.5M

Published: 12 November 2024

YCharOS antibody characterization platform addresses the “reproducibility crisis” in research...

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson’s, glioblastoma and dementia  

Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

An open solution to improving research reproducibility

Published: 18 December 2024

Academic and industry scientists collaborate on a new method to characterize research antibodies

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Published: 14 March 2025

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...

Project to create AI model for ALS receives Génome Québec funding

Published: 17 March 2025

$400,000 will fuel public-private collaboration to discover new disease biomarkers...

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

Published: 25 March 2025

Free, online training program strengthens training and brings specialized care to communities across Quebec...

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy...

Pages

Back to top